Eton Pharmaceuticals

Home
United States
Deer Park, IL
Eton Pharmaceuticals

Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.

11/26/2025

Wishing you a meaningful Thanksgiving from the Eton team.

This time of year reminds us why we do what we do. We’re grateful for the rare disease communities who share their experiences with us, the healthcare professionals who push for answers, and the partners who help move important work forward. Your dedication shapes every decision we make.

We’re thankful for the opportunity to support patients who rely on us and for the continued trust placed in our therapies and our team. It’s a responsibility we take to heart.

We hope your holiday is filled with good food, good company, and a moment to slow down and enjoy it all.

Happy Thanksgiving. 🦃🍁

11/26/2025

We were proud to attend the Raymond A. Wood Foundation Pituitary Brain Tumor Family Conference in Philadelphia on November 15 and 16.

The foundation is a parent and patient-led rare disease patient advocacy organization.

Their mission is to empower survivors of craniopharyngioma and hypothalamic-pituitary brain tumors with an improved quality of life by providing access to education, technology, and evolving treatments.

We valued the opportunity to meet patients and their families, listen to their stories, and learn about their journeys.

11/26/2025

We had a great experience at , The American Association for the Study of Liver Diseases (AASLD) "The Liver Meeting 2025".

The AASLD is the leading organization for advancing liver disease research, education, and clinical practice, bringing together experts dedicated to improving patient care.

It was a meaningful opportunity to connect with clinicians, researchers, and partners who are shaping the future of liver care.

Our team appreciated the thoughtful discussions, the insights shared throughout the meeting, and the chance to engage with so many dedicated liver disease professionals, including clinicians, researchers, and partners who are shaping the future of liver care.

Thank you to everyone who took the time to meet with us. We’re grateful for the conversations and look forward to building on the momentum from this year’s meeting.

11/26/2025

Eton Pharmaceuticals was honored to participate in the Wilson Disease Association 2025 Conference in Sacramento, California, led by Rhonda Rowland and the dedicated WDA team. The event brought together patients, caregivers, clinicians, and researchers who share a common goal: improving the lives of those affected by .

We’re proud to support the WDA’s mission through ongoing education, advocacy, and collaboration. Connecting directly with this inspiring community reminds us why we are and fuels our commitment to delivering meaningful therapies and comprehensive patient support through .

A special highlight of the weekend was the launch of the WDA’s Copper Conscious Cookbook, available on Amazon beginning December 6 on .

A heartfelt thank you to the WDA board members, team, and all participants for the important work you do each day to advance awareness, diagnosis, and treatment for Wilson disease.

09/25/2025

We’re heading to Denver! Eton Pharmaceuticals is proud to attend the American Academy of Pediatrics (AAP) 2025 National Conference & Exhibition from September 26–30.

Stop by Booth #453 to meet our team, learn more about our commitment to reimagining rare medicines, and explore how we support pediatric patients and their families.

We look forward to connecting with healthcare professionals, advocates, and partners dedicated to advancing pediatric care. See you in Denver!

09/16/2025

This week, we raise awareness of childhood growth disorders.

MAGIC’s motto says it best: Children have a short time to grow and a lifetime to live with the results. Help us raise awareness and share this message.

magicfoundation.org

09/16/2025

September is Newborn Screening Awareness Month

Every baby deserves the best start in life. Through , rare but serious conditions can be identified early, often before symptoms appear, so families can access the care and treatments they need. Early detection can make a lifelong difference.

This September, Eton joins the healthcare community in raising awareness and honoring the families, clinicians, and advocates who champion early intervention every day. 👣

07/08/2025

We’re proud to announce that the FDA has accepted our New Drug Application for ET-600, marking an important step forward in our commitment to advancing rare disease treatments.

At Eton, we are driven by our mission to bring innovative, meaningful therapies to patients who need them most. This milestone brings us closer to delivering a new treatment option for a rare condition with limited options.

🔗 Read the full press release here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-fda-acceptance-new-drug-1

05/29/2025

We’re proud to share that the U.S. FDA has approved KHINDIVI™ (hydrocortisone) Oral Solution, the latest addition to Eton Pharmaceuticals’ growing portfolio.

This approval reflects our ongoing commitment to advancing treatment options for individuals affected by rare conditions.

A sincere thank you to our internal team, clinical collaborators, and the entire rare disease community who made this achievement possible.

Read the full press release:
https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-us-fda-approval-khindivitm

Please see full package insert:
https://www.etonpharma.com/wp-content/uploads/2025/05/khindivi-pi.pdf

05/13/2025

Join Eton Pharmaceuticals at the 2025 Pediatric Endocrinology Society (PES) Annual Meeting at Booth #107 | May 15 – 18

We’re proud to support the pediatric endocrine community and the critical work being done to improve the lives of children with rare and chronic conditions.

Visit us at Booth #107 to learn more about our commitment to innovation in rare disease treatments and how we support pediatric patients and their families.

We look forward to connecting with you!

04/29/2025

Don’t miss us at the 2025 Pediatric Endocrinology Nursing Society (PENS) National Conference Booth #211 on April 30 – May 2, 2025!

Eton Pharmaceuticals is proud to support the pediatric endocrine community and the important work being done to advance care for children with rare and chronic conditions.

If you're attending, stop by our booth to learn more about our commitment to innovation in rare disease treatments and our growing portfolio designed to support pediatric patients and their families.

We look forward to connecting with you!

04/28/2025

We are proud to announce the submission of a New Drug Application (NDA) to the U.S. FDA for ET-600.

This milestone reflects our ongoing commitment to advancing therapies for patients with rare diseases and providing new options where there is a critical unmet need.

🔗 Read the full press release here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-submission-nda-et-600

Address

21925 W Field Pkwy #235
Deer Park, IL
60010

Website

https://www.etonpharma.com/

Alerts

Be the first to know and let us send you an email when Eton Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Eton Pharmaceuticals:

Shortcuts

Want your practice to be the top-listed Clinic in Deer Park?

Eton Pharmaceuticals

11/26/2025

11/26/2025

11/26/2025

11/26/2025

09/25/2025

09/16/2025

09/16/2025

07/08/2025

05/29/2025

05/13/2025

04/29/2025

04/28/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category